annual EBITDA:
$19.23M+$461.98M(+104.34%)Summary
- As of today (June 22, 2025), BPMC annual EBITDA is $19.23 million, with the most recent change of +$461.98 million (+104.34%) on December 31, 2024.
- During the last 3 years, BPMC annual EBITDA has risen by +$646.93 million (+103.06%).
- BPMC annual EBITDA is now -93.90% below its all-time high of $315.27 million, reached on December 31, 2020.
Performance
BPMC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$23.55M+$50.66M(+186.85%)Summary
- As of today (June 22, 2025), BPMC quarterly EBITDA is $23.55 million, with the most recent change of +$50.66 million (+186.85%) on March 31, 2025.
- Over the past year, BPMC quarterly EBITDA has dropped by -$85.65 million (-78.43%).
- BPMC quarterly EBITDA is now -96.29% below its all-time high of $635.01 million, reached on September 30, 2020.
Performance
BPMC quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$66.41M-$85.65M(-445.28%)Summary
- As of today (June 22, 2025), BPMC TTM EBITDA is -$66.41 million, with the most recent change of -$85.65 million (-445.28%) on March 31, 2025.
- Over the past year, BPMC TTM EBITDA has increased by +$153.50 million (+69.80%).
- BPMC TTM EBITDA is now -119.24% below its all-time high of $345.17 million, reached on June 30, 2021.
Performance
BPMC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BPMC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +104.3% | -78.4% | +69.8% |
| 3 y3 years | +103.1% | +123.3% | +89.5% |
| 5 y5 years | +105.4% | +121.0% | +82.5% |
BPMC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.1% | -78.4% | +115.2% | -445.3% | +90.3% |
| 5 y | 5-year | -93.9% | +103.1% | -96.3% | +107.6% | -119.2% | +90.3% |
| alltime | all time | -93.9% | +103.1% | -96.3% | +107.6% | -119.2% | +90.3% |
BPMC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $23.55M(-186.9%) | -$66.41M(-445.3%) |
| Dec 2024 | $19.23M(-104.3%) | -$27.11M(-18.8%) | $19.23M(-140.1%) |
| Sep 2024 | - | -$33.37M(+13.2%) | -$47.97M(-63.7%) |
| Jun 2024 | - | -$29.48M(-127.0%) | -$132.10M(-39.9%) |
| Mar 2024 | - | $109.20M(-215.8%) | -$219.91M(-50.3%) |
| Dec 2023 | -$442.75M(-14.3%) | -$94.32M(-19.7%) | -$442.75M(-9.0%) |
| Sep 2023 | - | -$117.51M(+0.2%) | -$486.66M(-0.4%) |
| Jun 2023 | - | -$117.28M(+3.2%) | -$488.46M(-7.2%) |
| Mar 2023 | - | -$113.64M(-17.8%) | -$526.28M(+2.5%) |
| Dec 2022 | -$516.84M(-17.7%) | -$138.23M(+15.9%) | -$513.56M(-25.1%) |
| Sep 2022 | - | -$119.31M(-23.1%) | -$685.26M(+1.0%) |
| Jun 2022 | - | -$155.10M(+53.7%) | -$678.17M(+7.6%) |
| Mar 2022 | - | -$100.91M(-67.4%) | -$629.98M(+0.4%) |
| Dec 2021 | -$627.70M(-299.1%) | -$309.94M(+176.2%) | -$627.70M(+56.1%) |
| Sep 2021 | - | -$112.21M(+4.9%) | -$402.05M(-216.5%) |
| Jun 2021 | - | -$106.92M(+8.4%) | $345.17M(+5.0%) |
| Mar 2021 | - | -$98.63M(+17.0%) | $328.72M(+4.3%) |
| Dec 2020 | $315.27M(-188.5%) | -$84.29M(-113.3%) | $315.26M(-5.0%) |
| Sep 2020 | - | $635.01M(-614.7%) | $331.75M(-183.0%) |
| Jun 2020 | - | -$123.37M(+10.1%) | -$399.93M(+5.4%) |
| Mar 2020 | - | -$112.09M(+65.3%) | -$379.26M(+6.5%) |
| Dec 2019 | -$356.07M | -$67.80M(-29.9%) | -$356.07M(-5.8%) |
| Sep 2019 | - | -$96.67M(-5.9%) | -$377.87M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$102.70M(+15.5%) | -$352.75M(+27.8%) |
| Mar 2019 | - | -$88.89M(-0.8%) | -$275.94M(+13.7%) |
| Dec 2018 | -$242.78M(+62.2%) | -$89.61M(+25.2%) | -$242.78M(+18.4%) |
| Sep 2018 | - | -$71.55M(+176.3%) | -$205.12M(+20.1%) |
| Jun 2018 | - | -$25.89M(-53.5%) | -$170.83M(-4.0%) |
| Mar 2018 | - | -$55.74M(+7.3%) | -$177.90M(+18.9%) |
| Dec 2017 | -$149.67M(+112.5%) | -$51.94M(+39.4%) | -$149.67M(+26.3%) |
| Sep 2017 | - | -$37.26M(+13.0%) | -$118.51M(+21.5%) |
| Jun 2017 | - | -$32.96M(+19.8%) | -$97.56M(+17.6%) |
| Mar 2017 | - | -$27.51M(+32.4%) | -$82.97M(+17.8%) |
| Dec 2016 | -$70.44M(+37.8%) | -$20.78M(+27.3%) | -$70.44M(+8.8%) |
| Sep 2016 | - | -$16.32M(-11.2%) | -$64.75M(+6.7%) |
| Jun 2016 | - | -$18.37M(+22.6%) | -$60.70M(+10.5%) |
| Mar 2016 | - | -$14.98M(-0.7%) | -$54.92M(+7.4%) |
| Dec 2015 | -$51.13M(+30.4%) | -$15.08M(+22.9%) | -$51.13M(+1.9%) |
| Sep 2015 | - | -$12.27M(-2.6%) | -$50.16M(+4.2%) |
| Jun 2015 | - | -$12.60M(+12.7%) | -$48.13M(+10.4%) |
| Mar 2015 | - | -$11.18M(-20.8%) | -$43.59M(+11.2%) |
| Dec 2014 | -$39.21M(+93.4%) | -$14.11M(+37.8%) | -$39.21M(+56.2%) |
| Sep 2014 | - | -$10.24M(+27.1%) | -$25.10M(+68.9%) |
| Jun 2014 | - | -$8.06M(+18.5%) | -$14.86M(+118.5%) |
| Mar 2014 | - | -$6.80M | -$6.80M |
| Dec 2013 | -$20.27M | - | - |
FAQ
- What is Blueprint Medicines annual EBITDA?
- What is the all time high annual EBITDA for Blueprint Medicines?
- What is Blueprint Medicines annual EBITDA year-on-year change?
- What is Blueprint Medicines quarterly EBITDA?
- What is the all time high quarterly EBITDA for Blueprint Medicines?
- What is Blueprint Medicines quarterly EBITDA year-on-year change?
- What is Blueprint Medicines TTM EBITDA?
- What is the all time high TTM EBITDA for Blueprint Medicines?
- What is Blueprint Medicines TTM EBITDA year-on-year change?
What is Blueprint Medicines annual EBITDA?
The current annual EBITDA of BPMC is $19.23M
What is the all time high annual EBITDA for Blueprint Medicines?
Blueprint Medicines all-time high annual EBITDA is $315.27M
What is Blueprint Medicines annual EBITDA year-on-year change?
Over the past year, BPMC annual EBITDA has changed by +$461.98M (+104.34%)
What is Blueprint Medicines quarterly EBITDA?
The current quarterly EBITDA of BPMC is $23.55M
What is the all time high quarterly EBITDA for Blueprint Medicines?
Blueprint Medicines all-time high quarterly EBITDA is $635.01M
What is Blueprint Medicines quarterly EBITDA year-on-year change?
Over the past year, BPMC quarterly EBITDA has changed by -$85.65M (-78.43%)
What is Blueprint Medicines TTM EBITDA?
The current TTM EBITDA of BPMC is -$66.41M
What is the all time high TTM EBITDA for Blueprint Medicines?
Blueprint Medicines all-time high TTM EBITDA is $345.17M
What is Blueprint Medicines TTM EBITDA year-on-year change?
Over the past year, BPMC TTM EBITDA has changed by +$153.50M (+69.80%)